T-regulatory cell response in psoriasis and changes with imatinib therapy.
Thachil
J
J
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D007111:Immunity, Cellular / Q000187:drug effects; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate